News

St. Jude Medical, acquires shares, Thoratec, heart failure, agreement

St. Jude Medical and Thoratec announced that the boards of directors of both companies have unanimously approved a definitive agreement under which St. Jude Medical will acquire all of the...

Thoratec, HeartMate PHP. CE Mark approval, SHIELD I

Thoratec announced that the HeartMate PHP (Percutaneous Heart Pump) received CE Mark approval, permitting sale in the European Union and other international countries. Approval was based on data...

Abiomed, U.S. headquarters expansion, Impella 2.5, RP, jobs

During an event with Massachusetts Gov. Charlie Baker in June, Abiomed announced a major expansion of its U.S. headquarters in Danvers, Massachusetts, and the creation of approximately 100 new,...

ECRI Institute, review, Impella RP, Abiomed

ECRI Institute recently reviewed published data on Abiomed’s Impella RP (Right Percutaneous) transcatheter ventricular assist device (VAD). The institute said the device provides immediate...

UH Case Medical Center, Impella RP, first in Ohio, Abiomed, Mobile Learning Lab

University Hospitals Case Medical Center physicians in the Harrington Heart & Vascular Institute were the first in Ohio to implant a new device to treat right ventricular heart disease.

Beaumont Hospital Royal Oak, Impella RP, right-side heart failure, Abiomed

Beaumont Hospital, Royal Oak is one of the first centers in the United States to use a new minimally invasive heart pump designed to provide temporary support for patients with severe right-side...

IABP, peer review, Maquet, Journal of Invasive Cardiology

Maquet Getinge Group announced the publication of a manuscript describing the exploration of the hemodynamic effects of the newer, larger-capacity 50 cc intra-aortic balloon pumps (IABPs) versus...

Thoratec, HeartMate II, ROADMAP

Thoratec Corp. announced results from the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients...

Protek Duo, VV ECLS, CE mark, CardiacAssist, veno-venous cannula

CardiacAssist Inc. announced that it received a Class 3 CE-mark for its Protek Duo veno-venous cannula. The Protek Duo is licensed for use as a single cannula for both venous drainage and...

intraaortic balloon pumps, IABP, ventricular assist devices, VAD, cost effective

Maquet Cardiovascular USA announced publication of a manuscript comparing the clinical and economic impact of percutaneous ventricular assist devices (pVAD) with intra-aortic balloon pumps (IABP)...

expert consensus, SCAI, ACC, HFSA, STS, heart pumps, MCS devices

An expert consensus statement released by four leading cardiovascular societies provides new guidance on percutaneous mechanical circulatory support (MCS) devices for treatment of heart failure....

SynCardia, Total Artificial Heart, 50cc, FDA, investigational study

SynCardia Systems Inc. has received U.S. Food and Drug Administration (FDA) approval to conduct an Investigational Device Exemption (IDE) clinical study on the effective use of its 50cc SynCardia...

Impella, FDA, high risk PCI, abiomed

The U.S. Food and Drug Administration (FDA) has granted pre-market approval (PMA) clearance for Abiomed’s Impella 2.5 heart pump during elective and urgent high-risk percutaneous coronary...

Artificial Heart, Ventricular Assist Device, Heart failure, SynCardia

SynCardia Systems Inc. has received U.S. Food and Drug Administration (FDA) approval to conduct a clinical study of the effectiveness of the SynCardia temporary Total Artificial Heart for...

Thoratec, HeartMate III, VAD, NewYork Presbyterian, trial, ventricular assist

NewYork-Presbyterian Hospital/Columbia University Medical Center is one of a select group of medical centers participating in a clinical trial of a new device for advanced heart failure patients,...

absorb, bioresorbable stents

DAIC readers chose the following stories as the most popular content in 2014, based on website analytics. The list is broken into the top 20 most popular news items from 2014 and a list of the top...

Hemodynamic support devices, Resuscitation Devices, Zoll Medical Corp.

Zoll Medical Corp. announced that it will acquire Advanced Circulatory Systems Inc.

syncardia, artificial heart

A 19-year-old woman was successfully implanted with the SynCardia temporary Total Artificial Heart and bridged to a donor heart transplant after cardiac surgeons used 3-D virtual...

CardiacAssist Inc. announced that the first Protek Duo veno-venous extracorporeal life support (VV ECLS) kit was utilized Sept. 24, at Memorial Hermann Hospital in Houston.

Clinical trial results by Recover Right revealed a survival rate of 73 percent in the total patient population. Recover Right was an FDA-approved, prospective, multicenter, single arm study...